Page last updated: 2024-10-31

milrinone and Retinopathy of Prematurity

milrinone has been researched along with Retinopathy of Prematurity in 1 studies

Retinopathy of Prematurity: A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"Milrinone is administered after patent ductus arteriosus (PDA) ligation to prevent and treat postoperative hemodynamic instability (i."1.91Effects of Milrinone on Neonates after Patent Ductus Arteriosus Ligation: A Retrospective Nationwide Database Study. ( Fujita, A; Ito, A; Kashima, K; Kato, M; Kitaoka, H; Konishi, T; Matsui, H; Shitara, Y; Takahashi, N; Yasunaga, H, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kitaoka, H1
Konishi, T1
Shitara, Y1
Ito, A1
Kashima, K1
Fujita, A1
Matsui, H1
Kato, M1
Takahashi, N1
Yasunaga, H1

Other Studies

1 other study available for milrinone and Retinopathy of Prematurity

ArticleYear
Effects of Milrinone on Neonates after Patent Ductus Arteriosus Ligation: A Retrospective Nationwide Database Study.
    Neonatology, 2023, Volume: 120, Issue:6

    Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Ductus Arteriosus, Patent; Enterocolitis, Necrotizi

2023